{
  "id": 12052145,
  "title": "Research into weight-loss drugs tipped for Nobel as award week opens",
  "url": "https://urgent.news/2026/10/05/research-into-weight-loss-drugs-tipped-for-nobel-as-award-week-opens",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-05T02:01:36.000Z",
  "source": {
    "name": "Gulf News",
    "slug": "gulf-news",
    "url": "https://gulfnews.com/world/research-into-weight-loss-drugs-tipped-for-nobel-as-award-week-opens-1.500698357"
  },
  "original_language": "en",
  "account": "This week marks the start of the 2026 Nobel Prize season, with the medicine prize set to be announced on Monday. Researchers studying hormones that regulate appetite are in the spotlight, as the work leading to weight-loss drugs like Ozempic and Mounjaro could earn a Nobel. The GLP-1 hormone, discovered through microbiome research and released by the intestine after eating, is a significant factor in these drugs' success. Experts believe GLP-1 is the top contender for the Nobel, given its global clinical impact. Other potential winners include Canadian endocrinologist Daniel Drucker, Danish physician Jens Juul Holst, and American chemist Svetlana Mojsov, all recognized for their contributions to the field.",
  "summary": null,
  "key_points": [
    "GLP-1 hormone discovered through microbiome research",
    "Weight-loss drugs Ozempic and Mounjaro impact global health",
    "GLP-1 and three scientists top contenders for Nobel Prize"
  ],
  "editors_take": "A Nobel Prize in medicine for research on appetite-regulating hormones could validate the scientific breakthroughs that led to the development of popular weight-loss drugs like Ozempic and Mounjaro.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}